United States· US:73292-011_0e3b8e29-64dd-430f-998d-5aca82258a8d

Viltepso

A viltolarsen product containing viltolarsen, registered in United States by NS Pharma, Inc.. The same ATC class is registered in 2 of our 19 countries.

ATC M09AX12US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedViltepsoATCM09AX12REGISTER NO.US:73292-011_0e3b8e29…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Viltolarsen is registered in 2 of 19 countries.

Countries holding a registration under ATC M09AX12 (viltolarsen), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose

Viltolarsen · ATC M09AX12

2 / 19 countries

  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
VILTOLARSEN
Manufacturer
NS Pharma, Inc.
Country
United States (US)
ATC code
M09AX12
ATC class
Viltolarsen
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    73292-011-01
  • ndc11
    7329201101
    1 VIAL, GLASS in 1 CARTON (73292-011-01) / 1 INJECTION, SOLUTION in 1 VIAL, GLASS

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under M09AX12

Viltolarsen, as other registers publish it.

All viltolarsen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f49f784c-c403-42f5-8454-57cbac6b5bb5
GET /v1/drugs/f49f784c-c403-42f5-8454-57cbac6b5bb5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "250",
  "substance": "VILTOLARSEN",
  "productndc": "73292-011",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA212154",
  "marketing_category": "NDA"
}

See everything about viltolarsen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.